Olena Nesterova

Olena Nesterova

Auto-generated profile, based on publicly available information

Olena Nesterova

Public Health Center of the Ministry of Health of Ukraine, Kyiv, Ukraine

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 May 2023 in International Journal of Drug Policy
Verified
Journal Article
Closed access
OMOlga Morozova
Olga Morozova
IIIryna Ivanchuk
Iryna Ivanchuk
OGOlga Gvozdetska
Olga Gvozdetska
ONOlena Nesterova
Olena Nesterova
PSPavlo Skala
Pavlo Skala
KDKostyantyn Dumchev
Kostyantyn Dumchev

24 July 2025 in Eurosurveillance
Verified
Journal Article
Open access
LKLudmila A Kasatkina
Ludmila A Kasatkina
VFVladyslav Fedorchenko
Vladyslav Fedorchenko
ISIryna Sidorova
Iryna Sidorova
LGLidia Gomenyuk
Lidia Gomenyuk
OYOleksandra Yakovets
Oleksandra Yakovets
ONOlena Nesterova
Olena Nesterova
BACKGROUND: Aligned with World Health Organization (WHO) goals, Ukraine aims to eliminate viral hepatitis. While some data on viral hepatitis B and C prevalence exist among key populations, nationwide prevalence in the general population has never been assessed. AIM: To assess the prevalence of viral hepatitis B, C, and D seromarkers in Ukraine in 2021 to plan and monitor elimination measures. METHODS: Blood samples available from a cross-sectional household-based SARS-CoV-2 serosurvey conducted in 2021 were tested for hepatitis C virus (HCV) antibodies, total antibodies against hepatitis B virus (HBV) core antigen (HBc), hepatitis B surface antigen (HBsAg) and hepatitis D virus (HDV) antibodies. We calculated crude and weighted proportions for anti-HCV, anti-HBc and HBsAg positivity. To account for differences in sex, age group and urbanisation level, we applied post-stratification weights using inverse probability weighting based on the distribution of the Ukrainian population. We calculated proportions positive for anti-HDV among HBsAg-positive cases and weighted regional estimates for HBV and HCV seromarkers. RESULTS: Weighted prevalence of anti-HCV was 3.3% (95% CI: 2.8–4.0), anti-HBc 11.6% (95% CI: 10.8–12.5) and HBsAg 0.9% (95% CI: 0.7–1.2). Among HBsAg-positive individuals, 7.5% (95% СI: 3.0–17.9) were anti-HDV positive. We found higher prevalence of HBV and HCV seromarkers among men and in southern Ukraine. CONCLUSION: HBsAg prevalence and considerably high anti-HBc and anti-HCV prevalence indicate substantial lifetime exposure. This reinforces the necessity of sustained prevention such as HBV vaccination of newborns and groups at increased risk, regular hepatitis B and C screening, early treatment, and raising awareness to reduce ongoing transmission.

30 January 2025 in JMIR Formative Research
Verified
Journal Article
Open access
NPNancy Puttkammer
Nancy Puttkammer
EDElizabeth Dunbar
Elizabeth Dunbar
MGMyroslava Germanovych
Myroslava Germanovych
MRMariia Rosol
Mariia Rosol
MGMatthew Golden
Matthew Golden
ONOlena Nesterova
Olena Nesterova
Background: Assisted partner services (APSs; sometimes called index testing) are now being brought to scale as a high-yield HIV testing strategy in many nations. However, the success of APSs is often hampered by low levels of partner elicitation. The Computer-Assisted Self-Interview (CASI)–Plus study sought to develop and test a mobile health (mHealth) tool to increase the elicitation of sexual and needle-sharing partners among persons with newly diagnosed HIV. CASI-Plus provides client-facing information on APS methods and uses a standardized, self-guided questionnaire with nonjudgmental language for clients to list partners who would benefit from HIV testing. The tool also enables health care workers (HCWs) to see summarized data to facilitate partner tracking. Objective: The formative research phase of the CASI-Plus study aimed to gather client and HCW input on the design of the CASI-Plus tool to ensure its acceptability, feasibility, and usability. Methods: This study gathered input to prioritize features and tested the usability of CASI-Plus with HCWs and clients receiving HIV services in public health clinics in wartime Ukraine. The CASI-Plus study’s formative phase, carried out from May 2023 to July 2024, adapted human-centered design (HCD) methods grounded in principles of empathy, iteration, and creative ideation. The study involved 3 steps: formative HCD, including in-depth individual interviews with clients, such as men who have sex with men and people who inject drugs, and internet-based design workshops with HCWs from rural and urban HIV clinics in Chernihiv and Dnipro; software platform assessment and heuristic evaluation, including assessment of open-source mHealth platforms against CASI-Plus requirements, prototype development, and testing of the REDCap (Research Electronic Data Capture) prototype based on usability heuristics; and usability walk-throughs, including simulated cases with HCWs and clients. Results: The formative phase of the CASI-Plus study included in-depth individual interviews with 10 clients and 3 workshops with 22 HCWs. This study demonstrated how simplified HCD methods, adapted to the wartime context, gathered rich input on prioritized features and tool design. The CASI-Plus design reflected features that are both culturally sensitive and in alignment with the constraints of Ukraine’s wartime setting. Prioritized features included information about the benefits of HIV index testing; a nonjudgmental, self-guided questionnaire to report partners; client stories; and bright images to accompany the text. Two-way SMS text messaging between clients and HCWs was deemed impractical based on risks of privacy breaches, national patient privacy regulations, and HCW workload. Conclusions: It was feasible to conduct HCD research in Ukraine in a wartime setting. The CASI-Plus mHealth tool was acceptable to both HCWs and clients. The next step for this research is a randomized clinical trial of the effect of the REDCap-based CASI-Plus tool on the number of partners named and the rate of partners completing HIV testing.

1 January 2024
Verified
Report
Closed access
PUPublic Health Center of the Ministry of Health of Ukraine
Public Health Center of the Ministry of Health of Ukraine
MMMariia Moshura
Mariia Moshura
YTYana Terleeva
Yana Terleeva
ONOlena Nesterova
Olena Nesterova
Modern technologies for diagnosing tuberculosis and effective treatment regimens contribute to the fight against the disease in various ways. In general, modern diagnostic and treatment technologies increase the chances of early detection and treatment of tuberculosis, reducing morbidity and improving quality of life. This aimed to determine the optimal model for the implementation of computer-aided diagnostic (CAD) systems in Ukrainian TB facilities in Lviv and Sumy oblasts. The study had the following components: Data collection from TB facilities included an assessment of the current workload of radiologists and physiologists. The staffing potential of the institutions and their technical equipment were determined to understand the ability to use CAD systems. The qualitative component of the study aimed to assess the attitude and acceptance of CAD among physicians, including radiologists, phthisiologists, and national experts, their views on possible models of CAD implementation, as well as to identify barriers and facilitators for CAD implementation. The calibration component of the study consisted of determining the optimal diagnostic characteristics and thresholds of the selected CAD in the local context and methods of its use. Cost estimation aimed to assess the economic cost of implementing CAD systems in Ukraine. CAD technology can improve the efficiency and practicality of radiography when used for TB screening and triage. In the Ukrainian context, this could be useful for TB control programs by expanding TB screening capacity. This technology can replace or complement human reading of X-rays during TB screening and helps to avoid differences in interpretation between examiners, as well as reduce delays in X-ray evaluation, especially in situations of lack of qualified personnel.

28 December 2025 in Modern pediatrics. Ukraine
Verified
Journal Article
Open access
PDF file
КMК.R. Marushko
К.R. Marushko
NUN.M. Usenko
N.M. Usenko
YKYu.S. Kotykovych
Yu.S. Kotykovych
OZO.A. Zaporozhska
O.A. Zaporozhska
ONO.YE. Nesterova
O.YE. Nesterova
Alcohol consumption during pregnancy is a serious threat to maternal and fetal health, leading to fetal alcohol syndrome (FAS) and other disorders. Despite the existence of international recommendations for prevention, there is no standardized model of counselling pregnant women on alcohol consumption in Ukraine. Aim - to study alcohol use behavior among women of reproductive age, including pregnant women, and assessed barriers, facilitators, and the feasibility of implementing an Alcohol Use Disorders Identification Test (AUDIT-C)-based counselling model for preventing fetal alcohol syndrome (FAS), as part of the The Joint Action Prevent Non-Communicable Diseases project. Materials and methods. Focus group discussions were conducted with healthcare professionals and women of reproductive age. The data were analyzed by content analysis using MaxQDA and Excel software. Results. After evaluation of the AUDIT-C-based counselling model healthcare providers indicated the following barriers: limited appointment time, insufficient preparation for motivational interviewing, and stigmatization of the topic. Women of reproductive age noted a low level of awareness of FAS and insufficient availability of information. Conclusions. The study revealed that doctor overload, stigma, and low awareness of alcohol-related risks among women are major barriers to implementation. Optimizing the model requires training of healthcare professionals and better access to reliable information. Proposed AUDIT-C-based counselling model is feasible and has potential to strengthen alcohol prevention efforts within routine antenatal care in Ukraine. Our data serves as a basis for making new counselling model more efficient and targeted. The authors declare that there is no conflict of interest.

18 October 2024 in JMIR Preprints
Verified
Preprint
Open access
NPNancy Puttkammer
Nancy Puttkammer
EDElizabeth Dunbar
Elizabeth Dunbar
MGMyroslava Germanovych
Myroslava Germanovych
MRMariia Rosol
Mariia Rosol
MGMatthew Golden
Matthew Golden
ONOlena Nesterova
Olena Nesterova
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet #Preprint #PeerReviewMe: Warning: This is a unreviewed preprint. Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn. Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period. Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author). Background: Assisted partner services (APSs; sometimes called index testing) are now being brought to scale as a high-yield HIV testing strategy in many nations. However, the success of APSs is often hampered by low levels of partner elicitation. The Computer-Assisted Self-Interview (CASI)–Plus study sought to develop and test a mobile health (mHealth) tool to increase the elicitation of sexual and needle-sharing partners among persons with newly diagnosed HIV. CASI-Plus provides client-facing information on APS methods and uses a standardized, self-guided questionnaire with nonjudgmental language for clients to list partners who would benefit from HIV testing. The tool also enables health care workers (HCWs) to see summarized data to facilitate partner tracking. Objective: The formative research phase of the CASI-Plus study aimed to gather client and HCW input on the design of the CASI-Plus tool to ensure its acceptability, feasibility, and usability. Methods: This study gathered input to prioritize features and tested the usability of CASI-Plus with HCWs and clients receiving HIV services in public health clinics in wartime Ukraine. The CASI-Plus study’s formative phase, carried out from May 2023 to July 2024, adapted human-centered design (HCD) methods grounded in principles of empathy, iteration, and creative ideation. The study involved 3 steps: formative HCD, including in-depth individual interviews with clients, such as men who have sex with men and people who inject drugs, and internet-based design workshops with HCWs from rural and urban HIV clinics in Chernihiv and Dnipro; software platform assessment and heuristic evaluation, including assessment of open-source mHealth platforms against CASI-Plus requirements, prototype development, and testing of the REDCap (Research Electronic Data Capture) prototype based on usability heuristics; and usability walk-throughs, including simulated cases with HCWs and clients. Results: The formative phase of the CASI-Plus study included in-depth individual interviews with 10 clients and 3 workshops with 22 HCWs. This study demonstrated how simplified HCD methods, adapted to the wartime context, gathered rich input on prioritized features and tool design. The CASI-Plus design reflected features that are both culturally sensitive and in alignment with the constraints of Ukraine’s wartime setting. Prioritized features included information about the benefits of HIV index testing; a nonjudgmental, self-guided questionnaire to report partners; client stories; and bright images to accompany the text. Two-way SMS text messaging between clients and HCWs was deemed impractical based on risks of privacy breaches, national patient privacy regulations, and HCW workload. Conclusions: It was feasible to conduct HCD research in Ukraine in a wartime setting. The CASI-Plus mHealth tool was acceptable to both HCWs and clients. The next step for this research is a randomized clinical trial of the effect of the REDCap-based CASI-Plus tool on the number of partners named and the rate of partners completing HIV testing.